- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1751-0759
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Effects of practicing yoga on alexisomia: an open-label trial ; volume:16 ; number:1 ; day:3 ; month:6 ; year:2022 ; pages:1-8 ; date:12.2022
BioPsychoSocial medicine ; 16, Heft 1 (3.6.2022), 1-8, 12.2022
- Creator
-
Oka, Takakazu
Lkhagvasuren, Battuvshin
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13030-022-00243-4
- URN
-
urn:nbn:de:101:1-2022080222142204963490
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Oka, Takakazu
- Lkhagvasuren, Battuvshin
- SpringerLink (Online service)
Other Objects (12)
IGF-1 in autosomal dominant cerebellar ataxia - open-label trial
An open-label feasibility trial of transdermal cannabidiol for hand osteoarthritis
Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study
Open-label placebos for menopausal hot flushes: a randomized controlled trial
Open-label placebos reduce weight in obesity: a randomized controlled trial
For Body and Mind: Practicing Yoga and Emotion Regulation
Trazodone for the treatment of fibromyalgia: an open-label, 12-week study
Botulinum toxin type A for painful diabetic neuropathy: an open-label study
Duloxetine in the treatment of major depressive disorder: an open-label study
Open-label, phase I, pharmacokinetic studies of abiraterone acetate in healthy men
Open-label placebo treatment does not enhance cognitive abilities in healthy volunteers
Nocturnal Asthma: Proof-of-Concept Open-Label Study with Delayed-Release Prednisone
IGF-1 in autosomal dominant cerebellar ataxia - open-label trial
An open-label feasibility trial of transdermal cannabidiol for hand osteoarthritis
Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study
Open-label placebos for menopausal hot flushes: a randomized controlled trial
Open-label placebos reduce weight in obesity: a randomized controlled trial
For Body and Mind: Practicing Yoga and Emotion Regulation
Trazodone for the treatment of fibromyalgia: an open-label, 12-week study
Botulinum toxin type A for painful diabetic neuropathy: an open-label study
Duloxetine in the treatment of major depressive disorder: an open-label study
Open-label, phase I, pharmacokinetic studies of abiraterone acetate in healthy men
Open-label placebo treatment does not enhance cognitive abilities in healthy volunteers
Nocturnal Asthma: Proof-of-Concept Open-Label Study with Delayed-Release Prednisone
IGF-1 in autosomal dominant cerebellar ataxia - open-label trial
An open-label feasibility trial of transdermal cannabidiol for hand osteoarthritis
Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study
Open-label placebos for menopausal hot flushes: a randomized controlled trial
Open-label placebos reduce weight in obesity: a randomized controlled trial
For Body and Mind: Practicing Yoga and Emotion Regulation
Trazodone for the treatment of fibromyalgia: an open-label, 12-week study
Botulinum toxin type A for painful diabetic neuropathy: an open-label study
Duloxetine in the treatment of major depressive disorder: an open-label study
Open-label, phase I, pharmacokinetic studies of abiraterone acetate in healthy men
Open-label placebo treatment does not enhance cognitive abilities in healthy volunteers